Real-World Effectiveness of Tirzepatide among People with Obesity or Overweight without Type 2 Diabetes (T2D)

被引：1
|
作者：
Hankosky, Emily R.
Desai, Karishma
Chinthammit, Chanadda
Grabner, Michael
Stockbower, Grace
He, Xuanyao
Mojdami, Donna
Wenziger, Cachet
Gibble, Theresa Hunter
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-2084-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2084-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [31] REAL WORLD INCIDENCE OF TYPE 2 DIABETES (T2D) COMPLICATIONS LEADING TO HOSPITALIZATION IN FRANCE: THE RECODE STUDY
    Bouee, S.
    Cochinaire, A.
    Godard, C.
    Sabater, F. J.
    Amelineau, E.
    Emery, C.
    Cotte, F. E.
    VALUE IN HEALTH, 2013, 16 (07) : A434 - A434
  • [32] Switching to Insulin Degludec from Insulin Glargine U100 Improves Glycemic Control in People with Type 1 (T1D) or Type 2 diabetes (T2D) in a Real-World Setting
    Knudsen, Soren T.
    Tentolouris, Nikolaos
    Schultes, Bernd
    Lapolla, Annunziata
    Eidenmueller, Markus
    Prager, Rudolf
    Catarig, Andrei-Mircea
    Wolden, Michael L.
    Siegmund, Thorsten
    DIABETES, 2018, 67
  • [33] Sex differences in the influence of type 2 diabetes (T2D)-related genes, parental history of T2D, and obesity on T2D development: a case-control study
    Berumen, Jaime
    Orozco, Lorena
    Gallardo-Rincon, Hector
    Rivas, Fernando
    Barrera, Elizabeth
    Benuto, Rosa E.
    Garcia-Ortiz, Humberto
    Marin-Medina, Melissa
    Juarez-Torres, Eligia
    Alvarado-Silva, Anabel
    Ramos-Martinez, Espiridion
    Martinez-Juarez, Luis Alberto
    Lomelin-Gascon, Julieta
    Montoya, Alejandra
    Ortega-Montiel, Janinne
    Alvarez-Hernandez, Diego-Abelardo
    Larriva-Shad, Jorge
    Tapia-Conyer, Roberto
    BIOLOGY OF SEX DIFFERENCES, 2023, 14 (01)
  • [34] Effectiveness of a screening program of type 2 diabetes (T2D) in Primary Care, and long-term incidence of T2D in Spain
    Gabriel, R.
    Vazquez-Fernandez, A.
    Marques, P.
    Novella, B.
    Moreno, S.
    Vega, S.
    Gonzalvez, L.
    Arranz, M.
    Melero, M. C.
    Montero Herrero, M. R.
    Acosta Vergara, T.
    Tuomilehto, J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [35] Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People with T2D
    Heise, Tim
    De Vries, J. Hans
    Coskun, Tamer
    Urva, Shweta
    Li, Jing
    Pratt, Edward J.
    Thomas, Melissa K.
    Mather, Kieren J.
    Dunn, Julia P.
    Haupt, Axel
    Milicevic, Zvonko
    DIABETES, 2022, 71
  • [36] CENTRAL ADIPOSITY AS A DRIVER OF THE TYPE 2 DIABETES (T2D) EPIDEMIC IN SAUDI PEOPLE
    Al-Khudairy, L.
    Rees, K.
    Kumar, S.
    Al-Dagheri, N.
    Al-Attas, O.
    Al-Okail, M.
    Al-Kharfy, K.
    Stranges, S.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2014, 68 : A51 - A51
  • [37] Efficacy of Tirzepatide in People with Young-Onset T2D in the SURPASS Program
    Zeitler, Philip
    Galindo, Rodolfo J.
    Davies, Melanie J.
    Bergman, Brandon
    Thieu, Vivian
    Nicolay, Claudia
    Allen, Sheryl
    Lee, Clare
    DIABETES, 2023, 72
  • [38] REAL WORLD EFFECTIVENESS OF DULAGLUTIDE AMONG PATIENTS WITH TYPE 2 DIABETES
    Mody, R.
    Yu, M.
    Fernandez, L.
    Shui, A.
    Kallenbach, L.
    Slipski, L.
    de Oliveira, Piras C.
    VALUE IN HEALTH, 2017, 20 (05) : A164 - A164
  • [39] A Real-World Evaluation of the Association between Cardiovascular Outcomes and T2D Therapy
    Thiel, Ellen
    Marder, William D.
    Cefalu, William T.
    Darsow, Tamara
    Petersen, Matt
    Latts, Lisa
    DIABETES, 2018, 67
  • [40] Outcomes among Patients with Type 2 Diabetes (T2D) Receiving Basal Insulin with Mealtime Insulin or Exenatide BID: A Retrospective Study Using Real-World EMR Data
    Lang, Kathleen
    Nguyen, Hiep
    Huang, Huan
    Kaufman, Elise
    Levin, Philip
    DIABETES, 2015, 64 : A428 - A428
12345